MoonLake Immunotherapeutics(MLTX)
ZUG, SwitzerlandBiotechnology
Focus: MoonLake Immunotherapeutics is a publicly traded Swiss biotech company focused on tri-specific nanobody therapeutics, primarily targeting dermatology and rheumatology indications. The company is early-stage (founded 2024) with 51-200 employees and a concentrated pipeline centered on Sonelokimab.
Profile data last refreshed 1h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
25+6 this month
Growing — net +6 jobs in 30d
16 jobs added vs 10 removed. Steady team buildout.
Should You Work at MoonLake Immunotherapeutics?
AI assessmentStrong near-term opportunity if you thrive in launch-stage, high-risk/high-reward environments with clear Phase 3 catalysts; higher attrition risk post-approval or clinical setback given narrow pipeline.
Why Work Here
- Access to novel tri-specific nanobody platform with potential structural advantages over conventional monoclonal antibodies in validated disease areas (hidradenitis suppurativa, psoriatic arthritis)
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
7 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Growing
Jobs increasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Sonelokimab
Relative BioequivalenceClinical Trials (1)
NCT06994936An Open-label Study in Healthy Adults to Evaluate the Relative Bioequivalence of a Single-dose Administration of Sonelokimab Either by a Prefilled Syringe or an Autoinjector
Phase 1Help build intelligence for MoonLake Immunotherapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.